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During the past two decades, our collec-
tive mastery of gene manipulation, deliv-
ery, and fluorescent fusion protein expres-
sion has been astounding and has enabled
never before dreamed of new lines of
research. These advances, coupled with
progress in the collection and analysis of
microscopy data, have allowed the scien-
tific community to detect proteins in live
cells with resolution that was unthinkable
not long ago. The confluence of protein
engineering and advanced microscopy has
enabled us to observe cellular processes
at the single molecule level and to begin
unraveling the mysteries of cellular bio-
chemistry and dynamics. These advances,
however, require delivery of a contrast
agent to the subject organism which can
sometimes lead to untoward effects and
potentially confounded results. Here, I
present an opinion on the need to improve
and deploy new strategies that allow for
the silent tagging of endogenous proteins
with contrast agents.
WHERE ART THOU, PROTEIN OF
INTEREST?
Visualization of cells has been enabled
by the use of simple organic and inor-
ganic dyes. The results of staining pro-
vides the ability to differentiate cell types
(e.g., hematoxylin vs. eosin stain) and
sometimes offers glimpses of complex cell
connectivity (e.g., chromium/silver Golgi
stain). In the case of brain tissue, these
stains can provide insight into neuronal
connectivity (Cajal, 1894). Of course, the
utility of these simple dyes and stains is
limited in scope to revealing snapshots in
time since they require fixation and some-
times development before imaging can be
performed.
Arguably, the most difficult challenge
facing biology and medicine is the deliv-
ery of contrast agents to the brain for the
purpose of visualizing the development,
plasticity, dysfunction, and degeneration
in live neural tissue. The majority of what
we know about brain dysfunction comes
from tissue snapshots collected from post-
mortem samples. These data are robust
and offer many insights into biochemical
and morphological underpinnings of dis-
ease, but the data that these methods can
reveal is, by definition, temporally limited
to the moment the fixative impregnates
the tissue. The detection of changes in
cell morphology or, of more relevance to
this opinion, responsive dynamic move-
ments of proteins in various subcellular
compartments, are lost once the fixative is
added.
HERE, PROTEIN OF INTEREST, CAN
YOU HOLD THIS?
Without question, the field of live cell flu-
orescence microscopy would be stalled if
it weren’t for the relatively recent discov-
ery and exploit of natural fluorescent pro-
teins and the boon in molecular biology
and genetic delivery strategies (Giepmans
et al., 2006). At first, it was the now
famous green fluorescent protein from
Aequorea victoria. Once the genetic code
for GFP was sequenced and packaged into
an expression vector, the genie was out
of the bottle. One would be hard-pressed
now to find any lab that works on ques-
tions in cell biology that does not have at
least one plasmid containing some form of
a boutique GFP variant.
In parallel to the explosion in pop-
ularity of GFP and variants thereof,
there continues to be the development of
new, organic based fluorescent molecules
(Mutze et al., 2012). Just when it seems
that chemists have exhausted the diversity
of chemical and structural space to pro-
duce new fluorophores, new ones come
along with different properties. These new
fluorophores offer combinations of funda-
mental photophysical properties; some are
long-lasting, some are bright (high quan-
tum yield), and some have large Stokes
shifts while others photobleach easily, are
dim, and excitation and emission wave-
lengths are not well-separated. However,
the old adage, in adapted form, holds here:
One molecule’s flaw is another molecule’s
feature. For instance, fast photobleach-
ing chromophores, if photo-reversible, are
vital to single molecule imaging tech-
niques used in stochastic optical recon-
struction microscopy (STORM imaging)
in which molecules are bleached and then
a small subset is stochastically turned back
on to reveal their sub-diffraction position
in space. It is clear that the menu of flu-
orophores is akin to selecting a fine wine;
to make an informed decision, one must
understand and appreciate the nuances of
the available options.
HOW DOWE DELIVER THESE
CONTRAST AGENTS TO THE PROTEIN
OF INTEREST?
The two main methods in use today to
deliver fluorescent chromophores to pro-
tein targets of interest are to use genetic
fusion modification of the target itself or
to employ a non-covalent delivery vehicle
such as an antibody that has been raised
to recognize a specific hapten on the target
molecule. Both of these methods are logis-
tically trivial and are routine in many cell
biology laboratories.
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With currently available commercial
technology, generation of a fusion protein
containing the target of interest is simple
and there are myriad transfection formu-
lations available to deliver the generated
plasmid to even the most difficult to trans-
fect cell types (in addition, of course, there
are virally-mediated delivery and trans-
genic strategies). The range of colors for
protein-based fluorophores is seemingly
infinite, allowing multiplexed experiments
(Giepmans et al., 2006) as well as genet-
ically encoded, photoactivatable proteins
for single particle tracking of parts of
organelles (Manley et al., 2008).
Antibody based delivery of contrast
agents has been used extensively in cell
biology studies. With advances in syn-
thetic chromophores and new methods
for the covalent attachment to antibod-
ies, delivery of these chromophores to tar-
gets on live cell surfaces is also becoming
routine. The exquisite specificity of the
antibody method, coupled with the diver-
sity of commercially available sources for
pre-stained antibodies, makes this method
very attractive when embarking on a new
study.
With all of the upsides of the genetic
and antibody methods, there are some
potential pitfalls and caveats that the
researcher must be aware of (Figure 1).
For instance, with fusion proteins and
transfection, it is difficult to specifically
control the expression level of the fusion
protein. This can sometimes result in con-
founded results, especially in cases where
the native protein is normally tightly
controlled by the cell. I would postu-
late that more examples of this confound
have been detected, but not reported due
to the nature of the null result. In the
neuroscience community, specific exam-
ples of this problem have been observed
in the fusion expression of certain ion
channels including the AMPA subtype
of glutamate receptors. The delicate bal-
ance of expression level and subcellu-
lar location is likely one of the most
important functions in maintaining com-
munication between two connected neu-
rons. The interplay of synaptic scaling,
both to enhance and diminish communi-
cation, is essential in both the developing
and developed nervous system (Jackson
et al., 2011; Bats et al., 2012; Opazo
et al., 2012; Lambo and Turrigiano, 2013).
Further, the insertion of the fluorescent
protein within a native protein can be dif-
ficult without severe perturbations of the
protein and/or proper protein targeting,
especially in mammalian systems (Baker
et al., 2007). More importantly, over-
expression of tagged-monomers of pro-
tein receptor subunits has been observed
to bias receptor subtype composition
thus confounding experimental results
(Bredt and Nicoll, 2003). However, these
issues can be circumvented in genetically-
tractable organisms by performing knock-
out/knock-in genetics so that the native
levels of the protein are maintained
as close as possible to the wild-type
state.
The antibody method of labeling native
proteins, by contrast, many times requires
the addition of largemultivalent molecules
as a primary antibody and then multiple
molecules of a similarly-sized secondary
antibody to track the movement of recep-
tors. While this method offers the benefit
of exquisite specificity due to the mul-
tivalent and immunologically optimized
interaction with the target, the large size
of typical primary antibodies in addition
to the size of typical secondary antibod-
ies may impose unforeseen consequences
when one would like to study natural
protein movements on the cell surface.
Additionally, when studying proteins that
may move into or out of the synapse, the
antibody method may be size-limited as to
what it can tell us regarding natural move-
ments of receptors and their movement
into or out of the synapse (Dahan et al.,
2003).
A COMPROMISE BETWEEN GENETICS
AND SIZE
Small affinity tags that specifically bind
a fluorescent probe, sometimes as small
as a single cysteine amino acid, can
be used to covalently attach a fluo-
rophore to a receptor (Griffin et al.,
1998; Marks et al., 2004; McCann et al.,
2005). In addition, new gene editing
strategies (Sun and Zhao, 2013) hold
great promise for installing either short
sequence motifs that can be recognized
by an exogenously applied chemical entity
(e.g., FlAsH, ReAsH, or RhoBo Adams
and Tsien, 2008; Halo et al., 2009) or
for the directed mutation of underlying
sequences that can be modified to produce
consensus sequences for a variety of post-
translational modifying enzymes (Lin and
Wang, 2008).
A DIFFERENT SOLUTION
A number of academic laboratories have
been developing ligand-targeted delivery
for contrast enhancement cargo (Cha
et al., 2005; Vytla et al., 2011; Ishida et al.,
2013). At the core of these strategies is the
ligand which directs the cargo to the right
place. By employing medicinal chemistry
literature and fundamental knowledge
of binding energies, tethered pharma-
cophores are being developed to allow
for the ligand to direct the sometimes-
covalent probe to the target protein or
receptor. This is where specificity becomes
difficult at times. Because targeting of the
receptor is reliant on the ligand, the best-
case scenario is one in which the teth-
ered ligand only binds to the intended
target. In reality, many pharmacophores
are believed to be specific at a certain
concentration, but off-target competitive
and allosteric sites are always rife in the
milieu of a cell or tissue. These are in addi-
tion to random collisions that can result
in covalent modification. Methods to test
the specificity of a ligand-directed probe
include competitive blockage of labeling,
use of orthogonal readouts (biochemical
activity, electrophysiology, binding inter-
action reporters, etc.). In the end, however,
it is difficult, if not impossible, to ever
definitively determine that a new probe
molecule is 100% specific for a desired tar-
get.While we can screen the known off-site
interactions, the real problem is that there
are likely unknown unknowns lurking on
the cells and tissue that result in off-target
labeling.
One strategy that we have been devel-
oping allows for non-invasive modifica-
tion of protein receptors with a small
molecular weight fluorophore for imaging
experiments. The strategy may be likened
to a molecular-scale bur that secretly sticks
to a receptor and provides a read-out
of receptor location. Our probes har-
bor a ligand (agonist, antagonist, or any
other ligand that maintains affinity for
the target protein) for targeting speci-
ficity, a fluorescent dye for optical moni-
toring of the receptor, and a promiscuous
electrophilic group for covalent coupling
to the target receptor. In addition, we
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FIGURE 1 | Graphic example of advantages and considerations of
each method of contrast agent delivery to proteins of interest.
The size scale of the glutamate receptor GluA2 structure [PDB: 3KG2
(Sobolevsky et al., 2009)], IgG (Clark, 1997), GFP [PDB: 1GFL (Yang
et al., 1996)], and Cy3 are identical. Each method for delivery of a
contrast agent and detection has advantages and potential confounds
that must be considered before embarking on experimental design,
investment, and execution.
have also engineered the probe system
so that the ligand can be excised from
the coupled system via simple and effi-
cient photolysis of the structural core
(Vytla et al.). After photolysis, the cou-
pled fluorescent probe/receptor complex
consists of a non-liganded receptor that
has a small fluorescent probe stuck to
its side. This allows for time-resolved
tracking of endogenous receptors that
can continue to function in their native
environment and respond to endogenous
ligands and then signal normally. This
has allowed us to now track labeled
receptors on live neurons and monitor
their movements in response to stim-
uli. In order to track receptor molecules
in their native state, it is important to
relieve persistently-agonized or antago-
nized receptors and avoid changes to the
receptor that are accompanied by ligand
binding. Agonist-induced conformational
changes of some receptors, such as the
glutamate receptors, have been shown
to induce clathrin-mediated endocytosis
of the receptors or differential traffick-
ing of these receptors (Nong et al., 2004;
Malinow et al., 2005; Dhami and Ferguson,
2006). In addition to agonist-induced
changes, antagonist-induced alterations
in receptor trafficking have also been
described (Carroll et al., 2001).
DESIRABLE PROPERTIES FOR
DELIVERY OF CONTRAST AGENTS TO
PROTEINS IN CELLS:
TRACELESS
The protein target, the cell, and the
observer should detect no difference
between the unlabeled (native state) and
the labeled form of the target protein.
Depending on the protein target, evidence
of lack of perturbation may be difficult to
prove.
SPECIFIC
The delivery of the contrast agent to the
protein of interest should be as specific as
possible. Off target labeling will confound
downstream results and should be avoided
at all costs.
HIGH CONTRAST
The contrast agent that is delivered should
be easy to detect from background signal.
For instance, a high quantum efficiency
fluorophore should be employed in the
case of fluorescence microscopy.
LONG TERM PROSPECTS FOR
TRACELESS LABELING
Traceless delivery of contrast agents to
endogenous proteins is the logical next
www.frontiersin.org March 2014 | Volume 2 | Article 11 | 3
Chambers Cargo delivery to endogenous proteins
step in garnering an unperturbed view
of the routines of proteins in live cells.
We, and others, continue to develop new
pharmacophores to enable ligand-directed
labeling of endogenous proteins. During
the next few years, it will be interest-
ing to compare chemically-enabled trace-
less labeling with the other two main
methods of protein detection; fluorescent
fusion protein expression and antibody-
based tracking. I suspect there will always
be a trade off between availability of
reagents, ease of use, and financial con-
siderations that will dictate which of these
now three methods one will choose for a
given experiment.
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